Skip to main content
SpringerLink
Log in

Combined therapy with infliximab and seton drainage for perianal fistulizing Crohn’s disease with anal endosonographic monitoring: a single-centre experience

  • Short Communication
  • Published:
Techniques in Coloproctology Aims and scope Submit manuscript

Abstract

During infliximab treatment of perianal Crohn’s disease (CD), the healing of the skin opening precedes fistula tract healing and this contributes to abscess formation and fistula recurrence. The aims of this study were to evaluate the efficacy of combined treatment with infliximab and setons for complex perianal fistulas in CD and to define the optimal time for seton removal by anal endosonography (AE). Nine consecutive patients with CD were studied. Perianal sepsis was eradicated when necessary and setons were placed before infliximab therapy. Setons were removed after AE evidence of fistulous tracts healing. Patients received a mean of 10±2.3 infliximab infusions. At week 6 all patients showed a reduction in mean CD activity index (p<0.005) and perianal disease activity index (p<0.0001). Complete fistula response was achieved in eight of nine patients. In six patients after a mean of 9.2 infusions, infliximab treatment was discontinued. Clinical and AE response persisted at 19.4±8.8 months (range 3–28 months) in five of these patients. One patient had fistula recurrence 20 weeks after infliximab discontinuation and responded rapidly to retreatment. At the time of this report, two patients were still on infliximab and in remission after a mean follow-up of 25±5 months. Combined therapy with infliximab and setons with AE monitoring of the response showed high efficacy in the management of patients with CD with complex perianal fistulas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Schwartz DA, Loftus EV, Tremaine WJ et al (2002) The natural history of fistulizing Crohn’s disease in Olmsted Country, Minnesota. Gastroenterology 122:875-80

    Article  PubMed  Google Scholar 

  2. Ardizzone S, Bianchi Porro G (2007) Perianal Crohn’s disease: overview. Dig Liver Dis 39:957-58

    Article  CAS  PubMed  Google Scholar 

  3. Ingle SB, Loftus EV Jr (2007) The natural history of perianal Crohn’s disease. Dig Liver Dis 39:963-69

    Article  CAS  PubMed  Google Scholar 

  4. Singh B, George BD, Mortensen NJ (2007) Surgical therapy of perianal Crohn’s disease. Dig Liver Dis 39:988-92

    Article  CAS  PubMed  Google Scholar 

  5. Sandborn WJ, Fazio VW, Feagan BG et al (2003) AGA technical review on perianal Crohn’s disease. Gastroenterology 125:1508-530

    Article  PubMed  Google Scholar 

  6. Griggs L, Schwartz DA (2007) Medical options for treating perianal Crohn’s disease. Dig Liver Dis 39:979-87

    Article  CAS  PubMed  Google Scholar 

  7. Present DH, Rutgeerts P, Targan S et al (1999) Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med 340:1398-405

    Article  CAS  PubMed  Google Scholar 

  8. Sands BE, Anderson FH, Bernstein CN et al (2004) Infliximab maintenance therapy for fistulizing Crohn’s disease. N Engl J Med 350:876-85

    Article  CAS  PubMed  Google Scholar 

  9. Rutgeerts P, Feagan BG, Lichtenstein GR et al (2004) Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease. Gastroenterology 126:402-13

    Article  CAS  PubMed  Google Scholar 

  10. Van der Hagen SJ, Baeten CG, Soeters PB et al (2005) Anti-TNF-alpha (infliximab) used as induction treatment of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn’s disease: a preliminary report. Dis Colon Rectum 48:758-67

    Article  PubMed  Google Scholar 

  11. Poggioli G, Laureti S, Pierangeli F et al (2005) Local injection of infliximab for the treatment of perianal Crohn’s disease. Dis Colon Rectum 48:768-74

    Article  CAS  PubMed  Google Scholar 

  12. Schroder O, Blumenstein I, Schulte-Bockholt A et al (2004) Combining infliximab and methotrexate in fistulizing Crohn’s disease resistant or intolerant to azathioprine. Aliment Pharmacol Ther 19:295-01

    Article  CAS  PubMed  Google Scholar 

  13. Ochsenkuhn T, Goke B, Sackmann M (2002) Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn’s disease. Am J Gastroenterol 97:2022-025

    PubMed  Google Scholar 

  14. Baert F, Noman M, Vermeire S et al (2003) Influence of immunogenicity on the long-term efficacy of infliximab in Crohn’s disease. N Engl J Med 348:601-08

    Article  CAS  PubMed  Google Scholar 

  15. Bell SJ, Halligan S, Windsor AC et al (2003) Response of fistulating Crohn’s disease to infliximab treatment assessed by magnetic resonance imaging. Aliment Pharmacol Ther 17:387-93

    Article  CAS  PubMed  Google Scholar 

  16. Ardizzone S, Maconi G, Colombo E et al (2004) Perianal fistulae following infliximab treatment: clinical and endosonographic outcome. Inflamm Bowel Dis 10:91-6

    Article  PubMed  Google Scholar 

  17. Regueiro M, Mardini H (2003) Treatment of perianal fistulizing Crohn’s disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis 9:98-03

    Article  PubMed  Google Scholar 

  18. Talbot C, Sagar PM, Johnston MJ et al (2005) Infliximab in the surgical management of complex fistulating anal Crohn’s disease. Colorectal Dis 7:164-68

    Article  CAS  PubMed  Google Scholar 

  19. Parks AG, Gordon PH, Hardcastle JD (1976) A classification of fistula in ano. Br J Surg 63:1-2

    Article  CAS  PubMed  Google Scholar 

  20. Cho DY (1999) Endosonographic criteria for an internal opening of fistula-in-ano. Dis Colon Rectum 42:515-18

    Article  CAS  PubMed  Google Scholar 

  21. Best WR, Becktel JM, Singleton JW et al (1976) Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology 70:439-44

    CAS  PubMed  Google Scholar 

  22. Irvine EJ (1995) Usual therapy improves perianal Crohn’s disease as measured by a new disease activity index. McMaster IBD Study Group. J Clin Gastroenterol 20:27-2

    Article  CAS  PubMed  Google Scholar 

  23. Schwartz DA, Wiersema MJ, Dudiak KM et al (2001) A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn’s perianal fistulas. Gastroenterology 121:1064-072

    Article  CAS  PubMed  Google Scholar 

  24. Felt-Bersma RJ (2006) Endoanal ultrasound in perianal fistulas and abscesses. Dig Liver Dis 38:537-43

    Article  CAS  PubMed  Google Scholar 

  25. Ardizzone S, Maconi G, Cassinotti A (2007) Imaging of perianal Crohn’s disease. Dig Liver Dis 39:970-78

    Article  CAS  PubMed  Google Scholar 

  26. van Bodegraven AA, Sloots CE, Felt-Bersma RJ et al (2002) Endosonographic evidence of persistence of Crohn’s disease-associated fistulas after infliximab treatment, irrespective of clinical response. Dis Colon Rectum 45:39-5

    Article  PubMed  Google Scholar 

  27. Rasul I, Wilson SR, MacRae H et al (2004) Clinical and radiological responses after infliximab treatment for perianal fistulizing Crohn’s disease. Am J Gastroenterol 99:82-8

    Article  CAS  PubMed  Google Scholar 

  28. Van Assche G, Vanbeckevoort D, Bielen D et al (2003) Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn’s disease. Am J Gastroenterol 98:332-39

    Article  PubMed  Google Scholar 

  29. Topstad DR, Panaccione R, Heine JA et al (2003) Combined seton placement, infliximab infusion, and maintenance immuno-suppressives improve healing rate in fistulizing anorectal Crohn’s disease: a single center experience. Dis Colon Rectum 46:577-83

    Article  PubMed  Google Scholar 

  30. Schwartz DA, White CM, Wise PE et al (2005) Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn’s perianal fistulas. Inflamm Bowel Dis 11:727-32

    Article  PubMed  Google Scholar 

  31. Hyder SA, Travis SP, Jewell DP et al (2006) Fistulating anal Crohn’s disease: results of combined surgical and infliximab treatment. Dis Colon Rectum 49:1837-841

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Medicina Interna Scienze Specialistiche e Dermatologia, Università Cattolica del Sacro Cuore, Rome, Italy

    L. Guidi, S. Semeraro, I. Roberto, I. De Vitis, A. Papa, M. Marzo, G. B. Doglietto, G. B. Gasbarrini & G. Fedeli

  2. Dipartimento di Scienze Chirurgiche, Università Cattolica del Sacro Cuore, Roma, Italy

    C. Ratto, A. Parello & G. Foglietto

Authors
  1. L. Guidi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Ratto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Semeraro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I. Roberto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I. De Vitis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Papa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Marzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A. Parello
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. G. Foglietto
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. G. B. Doglietto
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. G. B. Gasbarrini
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. G. Fedeli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. Guidi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guidi, L., Ratto, C., Semeraro, S. et al. Combined therapy with infliximab and seton drainage for perianal fistulizing Crohn’s disease with anal endosonographic monitoring: a single-centre experience. Tech Coloproctol 12, 111–117 (2008). https://doi.org/10.1007/s10151-008-0411-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10151-008-0411-0

Keywords

Search

Navigation